Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06535854 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06535854 · ClinicalTrials.gov record · last posted 2026-04-24

Prevail Global Study

Name: Prevail Global Study — clinical trial record (NCT06535854)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhaseNot applicable

SponsorMedtronic Vascular

Started2025-02-24

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

The purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB.

Amendment record 7 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 7 times since 2024-07-30; most recent amendment 2026-04-21. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2025-02-26

Status change Not Yet Recruiting→Recruitingv3

2024-10-24

Status change Withheld→Not Yet Recruitingv1

Trial Details

NCT Number	NCT06535854
Lead Sponsor	Medtronic Vascular
Conditions	Coronary Artery Disease
Enrollment	1,205 participants
Start Date	2025-02-24
Primary Completion	2027-02 (estimated)
Study Completion	2031-02 (estimated)
Updated on ClinicalTrials.gov	2026-04-24